Search
Search
NEWS CENTER
Position:
Homepage
/
/
/
China Pharmaceutical and Cosmetics Regulatory Policy Exchange Conference was held during the 3rd CIIE

China Pharmaceutical and Cosmetics Regulatory Policy Exchange Conference was held during the 3rd CIIE

  • Categories:Industry News
  • Author:
  • Origin:State Drug Administration
  • Time of issue:2021-07-08
  • Views:0

(Summary description)n the morning of November 6, sponsored by the National Medical Products Administration, China International Import Expo Bureau, Shanghai Municipal Medical Products Administration, China Chamber of Commerce for Import and Export of Medicines and Health Products, and China International Import Expo Exhibitors Alliance Public Health and Epidemic Prevention Committee of China The Pharmaceutical and Cosmetics Regulatory Policy Exchange Conference was held in Shanghai during the 3rd China International Import Expo.

China Pharmaceutical and Cosmetics Regulatory Policy Exchange Conference was held during the 3rd CIIE

(Summary description)n the morning of November 6, sponsored by the National Medical Products Administration, China International Import Expo Bureau, Shanghai Municipal Medical Products Administration, China Chamber of Commerce for Import and Export of Medicines and Health Products, and China International Import Expo Exhibitors Alliance Public Health and Epidemic Prevention Committee of China The Pharmaceutical and Cosmetics Regulatory Policy Exchange Conference was held in Shanghai during the 3rd China International Import Expo.

  • Categories:Industry News
  • Author:
  • Origin:State Drug Administration
  • Time of issue:2021-07-08
  • Views:0
Information

  On the morning of November 6, sponsored by the National Medical Products Administration, China International Import Expo Bureau, Shanghai Municipal Medical Products Administration, China Chamber of Commerce for Import and Export of Medicines and Health Products, and China International Import Expo Exhibitors Alliance Public Health and Epidemic Prevention Committee of China The Pharmaceutical and Cosmetics Regulatory Policy Exchange Conference was held in Shanghai during the 3rd China International Import Expo. Yan Jiangying, Deputy Director of the State Drug Administration, Yu Jianhua, Deputy Minister of Commerce, and Deputy Representative of International Trade Negotiations attended the meeting and delivered speeches. More than 130 representatives from the National Food and Drug Administration, the Ministry of Commerce, the National Medical Insurance Bureau, the drug regulatory bureaus of various provinces and cities, as well as domestic and overseas medical and cosmetic companies, and news media attended the exchange meeting.

  Yan Jiangying pointed out that China, as a major producer and consumer of pharmaceuticals, medical devices and cosmetics, is not only benefiting from the rapid development of the pharmaceutical industry, but also facing major opportunities and challenges brought about by the rapid development of new technologies in the pharmaceutical industry. The State Food and Drug Administration adheres to the guidance of Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, bears in mind the responsibility and mission of safeguarding the life and health of the public, implements the "four strictest" requirements, adheres to the reality, takes a global view, and adopts a more open and inclusive mind Continue to deepen the reform of the review, review and approval system, improve and improve the regulatory and standard system of drug supervision, vigorously promote the modernization of the regulatory system and regulatory capabilities, accelerate the launch of innovative products, and comprehensively improve the quality of China's manufacturing and innovation and development capabilities, and actively meet the needs of the Chinese public. Participating in international governance and contributing Chinese wisdom and strength to the global health cause.

  Since the outbreak of the new crown pneumonia, the State Food and Drug Administration has not relaxed its efforts in epidemic prevention and control, continuously optimized its work process, and concentrated its drug supervision forces to run "China speed", making a positive contribution to China's anti-epidemic struggle to achieve major strategic results. , To provide China's assistance for global epidemic prevention and control.

  Yan Jiangying said that we sincerely welcome the world’s outstanding pharmaceutical, medical device and cosmetics companies to come to China to bring the most advanced and high-quality products to China’s vast market and share new opportunities for China’s development. The State Food and Drug Administration also hopes that colleagues in the industry will do Advice and suggestions on China's drug regulation and the innovative development of the pharmaceutical industry.

  This exchange meeting is one of the supporting activities of the 3rd China International Import Expo. The meeting authoritatively interpreted the ideas and progress of China's pharmaceutical equipment registration and supervision, cosmetics supervision, medical care, and medical insurance payment methods, especially the interpretation of the upcoming "Cosmetics Supervision and Management" The Regulations have helped the majority of domestic and overseas enterprises to further understand the Chinese market and regulatory policies, and have received positive results.

Scan the QR code to read on your phone

Related news

Hubei LingZe  Pharmaceutical Technology Co.,Ltd.

Phone:13564147777(Mr. Ke)

Tel:0713-6512777

E-mail:15732718@qq.com

Add:Makou Pharmaceutical and Chemical Industrial Park, Tian Town, Wuxue City,Hubei Province

Hubei LingZe  Pharmaceutical Technology Co.,Ltd.

Mobile QR code

Copyright ©2021 lingzepharm.com All Rights Reserved     鄂ICP备2021012135号-1